Original Research ArticleInternational Journal of Reproduction, Contraception, Obstetrics and Gynecology

Publication:
Outcome of advanced epithelial ovarian cancer: a tertiary care centre study

Int J Reprod Contracept Obstet Gynecol. 2023;12(6):1644-1649.DOI10.18203/2320-1770.ijrcog20231529

Thumbnail Image
View on the journal's website(opens in a new tab)

Abstract

Background Ovarian cancer is the fourth most common cancer in Indian women with an incidence of 4.9 cases per 100,000. Epithelial ovarian cancer is a silent killer disease as it presents at an advanced stage with minimal signs and symptoms.

Methods It is a type of research article. The present study was conducted in Department of Obstetrics and Gynecology, Cama and Albless Hospital, Mumbai, Maharashtra, India, from a period of January 2018 to July 2019, during which 53 cases of EOC were studied.

Results Out of 53 cases of EOC, 45 cases were advanced stage EOC, they were either operated as PDS-ACT or NACT- IDS.

Conclusions NACT is recommended wherein optimal cytoreduction appears unlikely, or in patients where upfront surgery is high risk and extensive causing high morbidity post-surgery. Places where there is non-availability of special surgical expertise and hospital resources, there too NACT-IDS is recommended.

Keywords

Affiliations

  1. Department of Obstetrics and Gynecology, Grant Medical College and Sir J. J. Group of Hospitals, Mumbai, Maharashtra, India
  2. Department of Surgery, Grant Medical College and Sir J. J. Group of Hospitals, Mumbai, Maharashtra, India

Full item record